Automating the Acute Care Bottleneck

Getein 1600 Immunofluorescence Quantitative Analyzer | Fully Automated POCT Analyzer for High-Throughput Clinical Diagnostics

Point-of-care testing has long struggled to reconcile speed with scale. Portable analyzers are fast but low-throughput; central lab systems are robust but remote. The Getein 1600 bridges that gap with a fully automated system capable of 150 tests per hour and results in 3–15 minutes.

Its design targets the operational friction of emergency departments and ICUs. Random-access loading means urgent samples interrupt the queue without manual reconfiguration. The 48-sample capacity and 10 µL minimum volume reduce retesting delays and wasted draws.

The core technology is fluorescence immunoassay—mature, precise, and well-suited to panels for cardiac markers, infection, or D-dimer. The Android interface and LIS/HIS connectivity integrate the machine into existing hospital data ecosystems without proprietary lock-in.

China’s diagnostic device manufacturing has scaled rapidly on the back of domestic demand for distributed testing infrastructure. The Getein 1600 reflects that shift: it is not a premium import substitute but a purpose-built machine for high-volume, fast-turnaround environments where reliability must match cost discipline.

For hospital procurement teams, the relevant metric is not just throughput but uptime and reagent supply. A machine that operates as a single-vendor system simplifies logistics, particularly in tier-2 and tier-3 hospitals where service networks are thinner.

The real innovation here is less about a new detection principle than about compressing an entire lab workflow into a footprint that fits an exam room. That is where infrastructure meets clinical reality.

Why it matters:
This analyzer is a signal of how Chinese manufacturers are solving the throughput bottleneck in acute care diagnostics. For operators, it reduces manual error and cuts result latency. For buyers, it represents a domestically sourced alternative to centralized lab automation, with lower per-test economics.

View Product →